Records containing: Neurofibromatosis Type 1
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-10-16Evaluation of Preimplantation Genetic Diagnosis for Neurofibromatosis Type 1 (NF1), Emphasizing on the Molecular Aspects
-
CLINICAL_TRIALS study record update · 2024-09-27Phase I Trial of Intratumoral Administration of a NIS-Expressing Derivative Manufactured from a Genetically Engineered Strain of Measles Virus in Patients with Unresectable or Recurrent Malignant Peripheral Nerve Sheath Tumor
-
CLINICAL_TRIALS study record update · 2024-08-16Analysis of Stored Data Collected From Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols
-
CLINICAL_TRIALS study record update · 2024-07-16A Phase 2 Study of the MEK Inhibitor Trametinib (NSC# 763093) in Children With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
-
CLINICAL_TRIALS study record update · 2024-04-04A Paediatric Phase I/II Study Of Intermittent Dosing Of The Mek-1 Inhibitor Selumetinib In Children With Neurofibromatosis Type-1 And Inoperable Plexiform Neurofibroma And/Or Progressive Optic Pathway Glioma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-07Development of Stem Cell Lines in Children With Neurofibromatosis Type 1 and Tumors of the Central Nervous System
-
CLINICAL_TRIALS study record update · 2023-12-05Pilot Study of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) for Adults With Neurofibromatosis Type 1 (NF1) and Cutaneous Neurofibromas (CNF)
-
CLINICAL_TRIALS study record update · 2023-08-14The Efficacy of Selumetinib in Chinese Paediatric Participants With Post-operative Neurofibromatosis Type 1 (NF1)-Associated PNs: A PhaseⅡ, Multicenter, Randomised, Double-Blinded, Placebo-Controlled Study
-
CLINICAL_TRIALS study record update · 2023-04-26A Phase 1 Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Selumetinib, a Selective Mitogen Activated Protein Kinase Kinase (MEK) 1 Inhibitor, in Japanese Paediatric Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable and Symptomatic Plexiform Neurofibromas (PN)
-
CLINICAL_TRIALS study record update · 2023-03-03A Study Investigating the Test- and Retest Reliability of a Battery of Functional Standardised Outcome Measures in Adults With Neurofibromatosis 1
-
CLINICAL_TRIALS study record update · 2022-08-31Frameshift Peptides of Children With Neurofibromatosis Type 1 (NF1) and Either Low-Grade Gliomas or Plexiform Neurofibromas
-
CLINICAL_TRIALS study record update · 2022-04-25A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
-
CLINICAL_TRIALS study record update · 2022-03-03Multimodal Intervention Trial for Cognitive Deficits in Neurofibromatosis Type 1: Efficacy of Computerized Cognitive Training and Stimulant Medication
-
CLINICAL_TRIALS study record update · 2021-12-06Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain: A Phase III Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-11-30A Phase II Randomized Trial of Lenalidomide (NSC # 703813) in Pediatric Patients With Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
-
CLINICAL_TRIALS study record update · 2021-03-23Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2021-03-16Whole-body Vibration Training Compared to Muscle-strengthening Exercises Alone in Improving Muscle Function in Children With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2021-01-22Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
-
CLINICAL_TRIALS study record update · 2021-01-12Feasibility and Clinically Application of Magnetic Resonance Fingerprinting
-
CLINICAL_TRIALS study record update · 2020-10-08Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols
-
CLINICAL_TRIALS study record update · 2020-04-14The Effect of Lamotrigine on Cognitive Deficits Associated With Neurofibromatosis Type 1: a Phase II Randomized Controlled Multi-centre Trial (NF1-EXCEL)
-
CLINICAL_TRIALS study record update · 2019-12-16Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I
-
CLINICAL_TRIALS study record update · 2019-09-03Hypotonia as a Clinical Predictor of Optic Pathway Glioma in Children With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2019-02-25Multi-center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
-
CLINICAL_TRIALS study record update · 2019-02-25Multicenter Study of Tibial Dysplasia in Neurofibromatosis Type I (NF1) Patients